The inflammatory mammary tumor microenvironment should not be confused with “inflammatory breast cancer” (IBC), a rare (1%–6% of all breast malignancies) aggressive BC subtype with higher grade metastatic hormone receptor negative tumors that has been reviewed elsewhere [25,26]. The gene discussed is NR4A1; the disease is inflammatory breast carcinoma.